Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells
β Scribed by Nagathihalli S. Nagaraj; Nadarajah Vigneswaran; Wolfgang Zacharias
- Publisher
- Springer-Verlag
- Year
- 2005
- Tongue
- English
- Weight
- 623 KB
- Volume
- 132
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Tumor necrosis factorβrelated apoptosisβinducing ligand (TRAIL) is a promising cancer therapeutic agent because of its tumor selectivity. TRAIL is known to induce apoptosis in cancer cells but spare most normal cells. In this study, we examined whether treatment of docetaxel (DTX) can e
## Abstract In the treatment of colon cancer, the development of resistance to apoptosis is a major factor in resistance to therapy. New molecular approaches to overcome apoptosis resistance, such as selectively upregulating proapoptotic proteins, are needed in colon cancer therapy. In a mouse mode
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) holds great potential as an anticancer drug, since it induces selective cell death in cancer cells but not in normal ones. However, cancer cells often acquire resistance to TRAIL, which hinders its clinical efficacy. We previously demon